Back to results
US 2020/0345633 A1Published application
Pharmaceutical Compositions for Controlling and/or Reducing the Progression of Myopia
AssigneeBrien Holden Vision Institute Limited
InventorsMinas Theodore Coroneo, Monica Jong, Padmaja Rajagopal Sankaridurg, Earl Leo Smith, III, Amandeep Kaur
Life of this patent
Estimating the term…
Abstract
A pharmaceutical composition comprising a muscarinic antagonist and an adenosine antagonist for topical or ophthalmic application, and ophthalmic devices containing or delivering the same, and methods of using the same, for controlling and/or reducing the progression of myopia.
Claims20
An ophthalmic composition, comprising:
- i) a muscarinic receptor antagonist;
- and
- ii) an adenosine receptor antagonist.
Dependencies are inferred from the claim text.